OPRXNasdaqServices-Business Services, NECFiscal year ends December 31
OptimizeRx Corp
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$8.74+0.24 (+2.82%)
Close on Oct 19, 2026
- Market cap
- $164.19M
- P/E (TTM)
- 36.4
- Dividend yield
- –
Margins
Share of revenue, fiscal years 2011 to 2025
Gross margin
67.3%+11.6 pts over 5 years
Operating margin
10.7%+15.6 pts over 5 years
Net margin
4.7%+9.8 pts over 5 years
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | +18.8% | +20.6% | +20.4% | +31.2% | |
| Gross profit | +23.9% | +23.6% | +25.0% | +35.2% | |
| Free cash flow | +290.6% | +20.8% | – | +43.2% |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2016 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | -18.4% | -4.7% | 4.2% | |
| Return on assets | -12.9% | -3.8% | 2.9% | |
| Current ratio | 2.78 | 3.28 | 3.04 | |
| Debt to equity | – | – | 0.20 | |
| Net debt to EBITDA | – | – | 0.14× | |
| Interest coverage | – | – | 2.2× | |
| Capex to revenue | 2.3% | 0.2% | 0.1% | |
| Diluted shares | 10M | 15M | 19M |
Where the cash went
Fiscal 2021 to 2025, five years combined
OptimizeRx generated $42.22M from operations and spent $27.98M on capital expenditure, dividends and share buybacks. 2% of that went back into the business.
Generated
$42.22M
Used
$27.98M
Capital expenditure$438.33K2%Dividends$00%Share buybacks$27.55M98%
DuPont analysis
Return on equity split into margin, efficiency and leverage
Net margin4.7%
×Asset turnover0.63×
×Equity multiplier1.42×
=Return on equity, FY20254.2%
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | 4.7% | 0.63× | 1.42× | 4.2% |
| FY2024 | -21.8% | 0.52× | 1.46× | -16.5% |
| FY2023 | -24.6% | 0.45× | 1.26× | -13.9% |
| FY2022 | -18.3% | 0.45× | 1.07× | -8.9% |
| FY2021 | 0.6% | 0.61× | 1.11× | 0.4% |
| FY2020 | -5.1% | 0.74× | 1.23× | -4.7% |
| FY2019 | -12.8% | 0.60× | 1.29× | -9.9% |
| FY2018 | 1.1% | 1.22× | 1.41× | 1.8% |
| FY2017 | -17.3% | 1.14× | 1.51× | -30.0% |
| FY2016 | -19.9% | 0.65× | 1.42× | -18.4% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
8of 9 tests passed in fiscal 2025. Scores of 7 to 9 are usually read as strong.
- ProfitableNet income above zero$5.13M
- Cash generatingOperating cash flow above zero$18.72M
- Return on assets improvedROA up on the prior year-11.0% → 3.0%
- Earnings backed by cashOperating cash flow above net income$18.72M vs $5.13M
- Less leverageLong-term debt to assets fell18.0% → 12.1%
- Better liquidityCurrent ratio rose2.89 → 3.04
- No dilutionShare count did not rise18M → 19M
- Gross margin improvedGross margin up on the prior year64.45% → 67.25%
- More efficientAsset turnover rose0.50 → 0.64